{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T05:19:30Z","timestamp":1791523170749,"version":"4.3.4"},"reference-count":138,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009670","name":"National Alliance for Research on Schizophrenia and Depression","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009670","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["IOS-1557755"],"award-info":[{"award-number":["IOS-1557755"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008411","name":"Waterloo Institute for Nanotechnology, University of Waterloo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R03DA038734"],"award-info":[{"award-number":["R03DA038734"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004927","name":"Texas Historical Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004927","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.neuropharm.2020.108374","type":"journal-article","created":{"date-parts":[[2020,10,25]],"date-time":"2020-10-25T10:38:58Z","timestamp":1603622338000},"page":"108374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212\u20132 and heroin in adult male rats"],"prefix":"10.1016","volume":"182","author":[{"given":"Devan M.","family":"Gomez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Everett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsey R.","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajit","family":"Ranganath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph F.","family":"Cheer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik B.","family":"Oleson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2020.108374_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0014-2999(01)00873-1","article-title":"Spontaneous and precipitated withdrawal with a synthetic cannabinoid, WIN 55212-2","volume":"416","author":"Aceto","year":"2001","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108374_bib2","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/sj.npp.1301242","article-title":"Striatal vs extrastriatal dopamine D 2 receptors in antipsychotic response\u2014a double-blind PET study in schizophrenia","volume":"32","author":"Agid","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib3","first-page":"21","article-title":"Detection of synthetic cannabinoids in biological samples-a review","volume":"41","author":"Ammann","year":"2011","journal-title":"TIAFT Bull"},{"key":"10.1016\/j.neuropharm.2020.108374_bib4","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2018-2690","article-title":"Neuropsychiatric sequelae in adolescents with acute synthetic cannabinoid toxicity","volume":"144","author":"Anderson","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.neuropharm.2020.108374_bib5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/S0028-3908(01)00146-0","article-title":"Alterations in mesolimbic dopamine function during the abstinence period following chronic ethanol consumption","volume":"41","author":"Bailey","year":"2001","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib6","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1177\/0269881110382465","article-title":"Does intravenous \u03949-tetrahydrocannabinol increase dopamine release? A SPET study","volume":"25","author":"Barkus","year":"2011","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108374_bib7","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.biopsych.2018.04.019","article-title":"Cocaine-induced structural plasticity in input regions to distinct cell types in nucleus accumbens","volume":"84","author":"Barrientos","year":"2018","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108374_bib8","series-title":"Synthetic Cannabinoid and Cathinone Use Among US Soldiers","author":"Berry-Cab\u00e1n","year":"2012"},{"key":"10.1016\/j.neuropharm.2020.108374_bib9","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1007\/s00213-015-3915-0","article-title":"Further human evidence for striatal dopamine release induced by administration of\u0394 9-tetrahydrocannabinol (THC): selectivity to limbic striatum","volume":"232","author":"Bossong","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib10","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.pneurobio.2010.06.010","article-title":"Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia","volume":"92","author":"Bossong","year":"2010","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2020.108374_bib11","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/npp.2008.138","article-title":"\u03949-tetrahydrocannabinol induces dopamine release in the human striatum","volume":"34","author":"Bossong","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib12","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/S0022-3565(24)36967-8","article-title":"Regional differences in cannabinoid receptor\/G-protein coupling in rat brain","volume":"282","author":"Breivogel","year":"1997","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108374_bib13","first-page":"47","article-title":"The role of dopamine in schizophrenia from a neurobiological and evolutionary perspective: old fashioned, but still in vogue","volume":"5","author":"Brisch","year":"2014","journal-title":"Front. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108374_bib14","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1007\/s00213-007-0812-1","article-title":"Effects of chronic alcohol exposure on dopamine uptake in rat nucleus accumbens and caudate putamen","volume":"193","author":"Budygin","year":"2007","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib141","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fnbeh.2016.00248","article-title":"Acute depletion of D2 receptors from the rat substantia nigra alters dopamine kinetics in the dorsal striatum and drug responsivity","volume":"10","author":"Budygin","year":"2017","journal-title":"Frontiers Behav. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib15","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s002130100875","article-title":"Behavioural sensitization after repeated exposure to \u0394 9-tetrahydrocannabinol and cross-sensitization with morphine","volume":"158","author":"Cadoni","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib16","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/j.1471-4159.2008.05503.x","article-title":"Behavioral sensitization to \u03949\u2010tetrahydrocannabinol and cross\u2010sensitization with morphine: differential changes in accumbal shell and core dopamine transmission","volume":"106","author":"Cadoni","year":"2008","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.108374_bib17","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/jnc.12452","article-title":"Extended access of cocaine self\u2010administration results in tolerance to the dopamine\u2010elevating and locomotor\u2010stimulating effects of cocaine","volume":"128","author":"Calipari","year":"2014","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.108374_bib18","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.brainres.2013.10.039","article-title":"Chronic cannabinoid agonist (WIN 55,212-2) exposure alters hippocampal dentate gyrus spine density in adult rats","volume":"1542","author":"Candelaria-Cook","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108374_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1007\/s00429-014-0914-6","article-title":"Repeated administration of a synthetic cannabinoid receptor agonist differentially affects cortical and accumbal neuronal morphology in adolescent and adult rats","volume":"221","author":"Carvalho","year":"2016","journal-title":"Brain Struct. Funct."},{"key":"10.1016\/j.neuropharm.2020.108374_bib20","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1046\/j.1460-9568.2003.02409.x","article-title":"Cannabinoid withdrawal syndrome is reduced in double mu and delta opioid receptor knockout mice","volume":"17","author":"Casta\u00f1\u00e9","year":"2003","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/0091-3057(91)90367-B","article-title":"THC does not affect striatal dopamine release: microdialysis in freely moving rats","volume":"40","author":"Casta\u00f1eda","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108374_bib22","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1523\/JNEUROSCI.0529-04.2004","article-title":"Cannabinoids enhance subsecond dopamine release in the nucleus accumbens of awake rats","volume":"24","author":"Cheer","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib23","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1523\/JNEUROSCI.4152-06.2007","article-title":"Phasic dopamine release evoked by abused substances requires cannabinoid receptor activation","volume":"27","author":"Cheer","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib24","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0006-8993(93)90298-2","article-title":"Ventral tegmental microinjection of \u03949-tetrahydrocannabinol enhances ventral tegmental somatodendritic dopamine levels but not forebrain dopamine levels: evidence for local neural action by marijuana's psychoactive ingredient","volume":"621","author":"Chen","year":"1993","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108374_bib25","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1007\/BF02245916","article-title":"\u0394 9-tetrahydrocannabinol produces naloxone-blockable enhancement of presynaptic basal dopamine efflux in nucleus accumbens of conscious, freely-moving rats as measured by intracerebral microdialysis","volume":"102","author":"Chen","year":"1990","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib26","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1113\/jphysiol.2011.210807","article-title":"Distinct cellular properties of identified dopaminergic and GABAergic neurons in the mouse ventral tegmental area","volume":"589","author":"Chieng","year":"2011","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2020.108374_bib27","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1080\/09540260902782745","article-title":"Cannabis use disorder: epidemiology and management","volume":"21","author":"Copeland","year":"2009","journal-title":"Int. Rev. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108374_bib28","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.39945","article-title":"Dopamine neurons projecting to medial shell of the nucleus accumbens drive heroin reinforcement","volume":"7","author":"Corre","year":"2018","journal-title":"Elife"},{"key":"10.1016\/j.neuropharm.2020.108374_bib29","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.neuropharm.2017.04.033","article-title":"Endocannabinoid modulation of dopamine neurotransmission","volume":"124","author":"Covey","year":"2017","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib30","first-page":"S589","article-title":"Rapid changes in CB1 receptor availability in cannabis dependent males after abstinence from cannabis","author":"D'Souza","year":"2015","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib31","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.neuropharm.2004.06.032","article-title":"Dopamine and drug addiction: the nucleus accumbens shell connection","volume":"47","author":"Di Chiara","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib32","first-page":"2825","article-title":"Increase in meso\u2010prefrontal dopaminergic activity after stimulation of CB1 receptors by cannabinoids","volume":"10","author":"Diana","year":"1998","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib33","doi-asserted-by":"crossref","first-page":"7966","DOI":"10.1073\/pnas.90.17.7966","article-title":"Profound decrement of mesolimbic dopaminergic neuronal activity during ethanol withdrawal syndrome in rats: electrophysiological and biochemical evidence","volume":"90","author":"Diana","year":"1993","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.neuropharm.2020.108374_bib34","doi-asserted-by":"crossref","first-page":"14273","DOI":"10.1523\/JNEUROSCI.1894-10.2010","article-title":"Influence of phasic and tonic dopamine release on receptor activation","volume":"30","author":"Dreyer","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib35","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1007\/BF00428151","article-title":"Heroin and cocaine intravenous self-administration in rats: mediation by separate neural systems","volume":"78","author":"Ettenberg","year":"1982","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib36","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.drugalcdep.2011.01.012","article-title":"Synthetic cannabinoid JWH-018 and psychosis: an explorative study","volume":"117","author":"Every-Palmer","year":"2011","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2020.108374_bib37","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1097\/01.wnr.0000236853.40221.8e","article-title":"Cannabinoid self-administration increases dopamine release in the nucleus accumbens","volume":"17","author":"Fadda","year":"2006","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2020.108374_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyu097","article-title":"Behavioral and neurochemical changes in mesostriatal dopaminergic regions of the rat after chronic administration of the cannabinoid receptor agonist WIN55, 212-2","volume":"18","author":"Fanarioti","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neuropharm.2020.108374_bib39","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/j.1460-9568.2007.05470.x","article-title":"Bidirectional regulation of mu\u2010opioid and CB1\u2010cannabinoid receptor in rats self\u2010administering heroin or WIN 55,212\u20102","volume":"25","author":"Fattore","year":"2007","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib40","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1017\/S0033291715001178","article-title":"Examining the profile of high-potency cannabis and its association with severity of cannabis dependence","volume":"45","author":"Freeman","year":"2015","journal-title":"Psychol. Med."},{"key":"10.1016\/j.neuropharm.2020.108374_bib41","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.neuropharm.2018.05.018","article-title":"Exposure to cannabinoid agonist WIN 55,212-2 during early adolescence increases alcohol preference and anxiety in CD1 mice","volume":"137","author":"Frontera","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib42","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1146\/annurev.neuro.27.070203.144206","article-title":"Desensitization of G protein\u2013coupled receptors and neuronal functions","volume":"27","author":"Gainetdinov","year":"2004","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib43","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/BF02431546","article-title":"Facilitation of brain stimulation reward by\u0394 9-tetrahydrocannabinol","volume":"96","author":"Gardner","year":"1988","journal-title":"Psychopharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2020.108374_bib140","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0306-4522(03)00005-8","article-title":"A role for presynaptic mechanisms in the actions of nomifensine and haloperidol","volume":"118","author":"Garris","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108374_bib44","doi-asserted-by":"crossref","first-page":"3637","DOI":"10.1007\/s00213-015-4023-x","article-title":"Cross-tolerance to cannabinoids in morphine-tolerant rhesus monkeys","volume":"232","author":"Gerak","year":"2015","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0014-2999(97)01442-8","article-title":"Cannabinoids activate mesolimbic dopamine neurons by an action on cannabinoid CB1 receptors","volume":"341","author":"Gessa","year":"1998","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108374_bib46","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1002\/hipo.20706","article-title":"Recruitment of hippocampal neurons to encode behavioral events in the rat: alterations in cognitive demand and cannabinoid exposure","volume":"20","author":"Goonawardena","year":"2010","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuropharm.2020.108374_bib47","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1682\/JRRD.2008.04.0049","article-title":"Sustained antinociceptive effect of cannabinoid receptor agonist WIN 55,212-2 over time in rat model of neuropathic spinal cord injury pain","volume":"46","author":"Hama","year":"2009","journal-title":"J. Rehabil. Res. Dev."},{"key":"10.1016\/j.neuropharm.2020.108374_bib48","doi-asserted-by":"crossref","first-page":"107847","DOI":"10.1016\/j.neuropharm.2019.107847","article-title":"c-Jun N terminal kinase signaling pathways mediate cannabinoid tolerance in an agonist-specific manner","volume":"164","author":"Henderson-Redmond","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib49","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/syn.20844","article-title":"Differential developmental trajectories for CB1 cannabinoid receptor expression in limbic\/associative and sensorimotor cortical areas","volume":"65","author":"Heng","year":"2011","journal-title":"Synapse"},{"key":"10.1016\/j.neuropharm.2020.108374_bib50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/BF00431774","article-title":"Morphine and \u0394 9-tetrahydrocannabinol: two-way cross tolerance for antinociceptive and heart-rate responses in the rat","volume":"87","author":"Hine","year":"1985","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib51","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1038\/mp.2011.82","article-title":"Reversible and regionally selective downregulation of brain cannabinoid CB 1 receptors in chronic daily cannabis smokers","volume":"17","author":"Hirvonen","year":"2012","journal-title":"Mol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108374_bib52","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International union of pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2020.108374_bib53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuropharm.2004.07.030","article-title":"Cannabinoid physiology and pharmacology: 30 years of progress","volume":"47","author":"Howlett","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib54","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1523\/JNEUROSCI.1165-19.2019","article-title":"Cannabis and the developing brain: insights into its long-lasting effects","volume":"39","author":"Hurd","year":"2019","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib56","doi-asserted-by":"crossref","first-page":"16446","DOI":"10.1073\/pnas.1105418108","article-title":"Neuronal circuits underlying acute morphine action on dopamine neurons","volume":"108","author":"Jalabert","year":"2011","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.neuropharm.2020.108374_bib57","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bbr.2006.06.027","article-title":"Tolerance to the reinforcing effects of morphine in delta9-tetrahydrocannabinol treated mice","volume":"173","author":"Jardinaud","year":"2006","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108374_bib58","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.1523\/JNEUROSCI.19-10-03773.1999","article-title":"Distinct domains of the CB1 cannabinoid receptor mediate desensitization and internalization","volume":"19","author":"Jin","year":"1999","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib59","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1037\/pha0000271","article-title":"Behavioral effects of chronic WIN 55,212-2 administration during adolescence and adulthood in mice","volume":"27","author":"Johnson","year":"2019","journal-title":"Exp. Clin. Psychopharmacol"},{"key":"10.1016\/j.neuropharm.2020.108374_bib60","doi-asserted-by":"crossref","first-page":"718","DOI":"10.7205\/MILMED-D-10-00356","article-title":"Spice: a legal marijuana equivalent","volume":"176","author":"Johnson","year":"2011","journal-title":"Mil. Med."},{"key":"10.1016\/j.neuropharm.2020.108374_bib61","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0306-4522(03)00070-8","article-title":"Neuroanatomical relationship between type 1 cannabinoid receptors and dopaminergic systems in the rat basal ganglia","volume":"119","author":"Julian","year":"2003","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuropharm.2020.108374_bib62","doi-asserted-by":"crossref","first-page":"6480","DOI":"10.1523\/JNEUROSCI.5073-13.2014","article-title":"Differential effects of presynaptic versus postsynaptic adenosine A2A receptor blockade on \u03949-tetrahydrocannabinol (THC) self-administration in squirrel monkeys","volume":"34","author":"Justinov\u00e1","year":"2014","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib63","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1124\/mol.104.006882","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?","volume":"67","author":"Kearn","year":"2005","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108374_bib64","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/1044-5765(92)90012-Q","article-title":"Dopamine, addiction and reward","author":"Koob","year":"1992","journal-title":"Semin. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib65","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0006-8993(00)02739-6","article-title":"Changes in hippocampal morphology following chronic treatment with the synthetic cannabinoid WIN 55,212-2","volume":"877","author":"Lawston","year":"2000","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108374_bib66","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/npp.2011.302","article-title":"Inhibitory inputs from rostromedial tegmental neurons regulate spontaneous activity of midbrain dopamine cells and their responses to drugs of abuse","volume":"37","author":"Lecca","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib67","series-title":"Cannabinoid Tolerance and Dependence","first-page":"691","author":"Lichtman","year":"2005"},{"key":"10.1016\/j.neuropharm.2020.108374_bib68","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1101\/lm.1081908","article-title":"Chronic cannabinoid administration in vivo compromises extinction of fear memory","volume":"15","author":"Lin","year":"2008","journal-title":"Learn. Mem."},{"key":"10.1016\/j.neuropharm.2020.108374_bib69","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0022-3565(25)13256-4","article-title":"Pharmacology and stereoselectivity of structurally novel cannabinoids in mice","volume":"247","author":"Little","year":"1988","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2020.108374_bib70","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.ejphar.2011.04.010","article-title":"The effect of chronic opioid vs. cannabinoid exposure on the expression of tolerance to morphine-or WIN-55,212-2-induced analgesia and hypothermia in the Guinea pig","volume":"660","author":"Maguma","year":"2011","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108374_bib72","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-6147(99)01339-5","article-title":"Pharmacological and biochemical interactions between opioids and cannabinoids","volume":"20","author":"Manzanares","year":"1999","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib73","volume":"20","author":"Martz","year":"2018"},{"key":"10.1016\/j.neuropharm.2020.108374_bib74","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.neuron.2014.04.030","article-title":"Separate GABA afferents to dopamine neurons mediate acute action of opioids, development of tolerance, and expression of withdrawal","volume":"82","author":"Matsui","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.neuropharm.2020.108374_bib75","doi-asserted-by":"crossref","first-page":"17729","DOI":"10.1523\/JNEUROSCI.4570-11.2011","article-title":"Opioid-sensitive GABA inputs from rostromedial tegmental nucleus synapse onto midbrain dopamine neurons","volume":"31","author":"Matsui","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib76","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.neuropharm.2007.05.028","article-title":"Identification of the sites of 2-arachidonoylglycerol synthesis and action imply retrograde endocannabinoid signaling at both GABAergic and glutamatergic synapses in the ventral tegmental area","volume":"54","author":"M\u00e1ty\u00e1s","year":"2008","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib77","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.bbr.2010.01.024","article-title":"Chronic WIN55, 212-2 elicits sustained and conditioned increases in intracranial self-stimulation thresholds in the rat","volume":"209","author":"Mavrikaki","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108374_bib78","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnint.2013.00093","article-title":"Sex-specific tonic 2-arachidonoylglycerol signaling at inhibitory inputs onto dopamine neurons of Lister Hooded rats","volume":"7","author":"Melis","year":"2013","journal-title":"Front. Integr. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib79","doi-asserted-by":"crossref","first-page":"10707","DOI":"10.1523\/JNEUROSCI.3502-04.2004","article-title":"Prefrontal cortex stimulation induces 2-arachidonoyl-glycerol-mediated suppression of excitation in dopamine neurons","volume":"24","author":"Melis","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib80","series-title":"The Dopamine Hypothesis of Drug Addiction: Hypodopaminergic State","author":"Melis","year":"2005"},{"key":"10.1016\/j.neuropharm.2020.108374_bib81","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/npp.2017.143","article-title":"The role of the endocannabinoid system and genetic variation in adolescent brain development","volume":"43","author":"Meyer","year":"2018","journal-title":"Neuropsychopharmacology"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2020.108374_bib139","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0731-7085(98)00145-9","article-title":"Electrochemical monitoring of biogenic amine neurotransmission in real time","volume":"19","author":"Michael","year":"1999","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.neuropharm.2020.108374_bib82","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00210-008-0337-0","article-title":"Chronic treatment and withdrawal of the cannabinoid agonist WIN 55,212-2 modulate the sensitivity of presynaptic receptors involved in the regulation of monoamine syntheses in rat brain","volume":"379","author":"Moranta","year":"2009","journal-title":"N. Schmied. Arch. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108374_bib83","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1111\/adb.12694","article-title":"Cannabinoid dependence induces sustained changes in GABA release in the globus pallidus without affecting dopamine release in the dorsal striatum: a dual microdialysis probe study","volume":"23","author":"Moreno","year":"2018","journal-title":"Addiction Biol."},{"key":"10.1016\/j.neuropharm.2020.108374_bib84","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/jnc.14549","article-title":"Chronic, intermittent treatment with a cannabinoid receptor agonist impairs recognition memory and brain network functional connectivity","volume":"147","author":"Mouro","year":"2018","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.108374_bib85","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1523\/JNEUROSCI.21-14-05344.2001","article-title":"Functional interaction between opioid and cannabinoid receptors in drug self-administration","volume":"21","author":"Navarro","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib86","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neuropharm.2018.12.026","article-title":"Tolerance to WIN55, 212-2 is delayed in desensitization-resistant S426A\/S430A mice","volume":"148","author":"Nealon","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib87","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.biopsych.2011.11.027","article-title":"\u03b2-Arrestin2 regulates cannabinoid CB1 receptor signaling and adaptation in a central nervous system region\u2013dependent manner","volume":"71","author":"Nguyen","year":"2012","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108374_bib88","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/nrn3939","article-title":"The dopamine theory of addiction: 40 years of highs and lows","volume":"16","author":"Nutt","year":"2015","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib89","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1111\/j.1360-0443.2010.03144.x","article-title":"Addiction and dependence in DSM\u2010V","volume":"106","author":"O'Brien","year":"2011","journal-title":"Addiction"},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108374_bib90","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.neuron.2011.11.018","article-title":"Endocannabinoids shape accumbal encoding of cue-motivated behavior via CB1 receptor activation in the ventral tegmentum","volume":"73","author":"Oleson","year":"2012","journal-title":"Neuron."},{"issue":"6","key":"10.1016\/j.neuropharm.2020.108374_bib91","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1038\/npp.2013.340","article-title":"Cannabinoid receptor activation shifts temporally engendered patterns of dopamine release","volume":"39","author":"Oleson","year":"2014","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib92","doi-asserted-by":"crossref","first-page":"a012229","DOI":"10.1101\/cshperspect.a012229","article-title":"A brain on cannabinoids: the role of dopamine release in reward seeking","volume":"2","author":"Oleson","year":"2012","journal-title":"Cold Spring Harbor perspectives in medicine"},{"issue":"5","key":"10.1016\/j.neuropharm.2020.108374_bib93","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1038\/npp.2008.186","article-title":"Dopamine uptake changes associated with cocaine self-administration","volume":"34","author":"Oleson","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib94","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1111\/dar.12372","article-title":"Novel psychoactive substance use by US adolescents: characteristics associated with use of synthetic cannabinoids and synthetic cathinones","volume":"35","author":"Patrick","year":"2016","journal-title":"Drug Alcohol Rev."},{"key":"10.1016\/j.neuropharm.2020.108374_bib95","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1471-4159.2012.07738.x","article-title":"Differential regulation of accumbal dopamine transmission in rats following cocaine, heroin and speedball self\u2010administration","volume":"122","author":"Pattison","year":"2012","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.108374_bib96","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0091-3057(91)90384-E","article-title":"The pharmacologic effects of daily marijuana smoking in humans","volume":"40","author":"Perez-Reyez","year":"1991","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108374_bib97","series-title":"A Brain on Cannabinoids: the Role of Dopamine Release in Reward Seeking and Addiction. Cold Spring Harbor Perspectives in Medicine","first-page":"a039305","author":"Peters","year":"2020"},{"key":"10.1016\/j.neuropharm.2020.108374_bib98","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/BF00427441","article-title":"Destruction of dopamine in the nucleus accumbens selectively attenuates cocaine but not heroin self-administration in rats","volume":"84","author":"Pettit","year":"1984","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib99","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/S0006-8993(02)03055-X","article-title":"\u03949-Tetrahydrocannabinol decreases extracellular GABA and increases extracellular glutamate and dopamine levels in the rat prefrontal cortex: an in vivo microdialysis study","volume":"948","author":"Pistis","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108374_bib100","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.bbr.2013.03.015","article-title":"Involvement of CB1 receptors in the ventral tegmental area in the potentiation of morphine rewarding properties in acquisition but not expression in the conditioned place preference model","volume":"247","author":"Rashidy-Pour","year":"2013","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108374_bib101","series-title":"Handbook of Behavioral Neuroscience","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/B978-0-12-802206-1.00034-9","article-title":"Phasic dopamine signaling in action selection and reinforcement learning","author":"Redgrave","year":"2016"},{"key":"10.1016\/j.neuropharm.2020.108374_bib102","doi-asserted-by":"crossref","first-page":"11070","DOI":"10.1523\/JNEUROSCI.3695-04.2004","article-title":"Independent presynaptic and postsynaptic mechanisms regulate endocannabinoid signaling at multiple synapses in the ventral tegmental area","volume":"24","author":"Riegel","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib103","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjp.0706757","article-title":"\u03bc opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis","volume":"148","author":"Rios","year":"2006","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.neuropharm.2020.108374_bib138","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1021\/acschemneuro.6b00393","article-title":"Hitchhiker\u2019s guide to voltammetry: acute and chronic electrodes for in vivo fast-scan cyclic voltammetry","volume":"8","author":"Rodeberg","year":"2017","journal-title":"ACS Chemi. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib104","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0024-3205(00)00547-6","article-title":"Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome","volume":"66","author":"Rubino","year":"2000","journal-title":"Life Sci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib105","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.tips.2004.12.007","article-title":"Why does the rapid delivery of drugs to the brain promote addiction?","volume":"26","author":"Samaha","year":"2005","journal-title":"Trends Pharmacol. Sci."},{"issue":"1","key":"10.1016\/j.neuropharm.2020.108374_bib106","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1124\/jpet.117.241802","article-title":"Diazepam Concurrently Increases the Frequency and Decreases the Amplitude of Transient Dopamine Release Events in the Nucleus Accumbens","volume":"364","author":"Schelp","year":"2018","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"key":"10.1016\/j.neuropharm.2020.108374_bib107","doi-asserted-by":"crossref","first-page":"9991","DOI":"10.1073\/pnas.1920866117","article-title":"Cannabinoid exposure in rat adolescence reprograms the initial behavioral, molecular, and epigenetic response to cocaine","volume":"117","author":"Scherma","year":"2020","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"key":"10.1016\/j.neuropharm.2020.108374_bib109","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neuropharm.2006.05.019","article-title":"Interactions between CB1 cannabinoid and \u03bc opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core","volume":"51","author":"Schoffelmeer","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib110","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.nlm.2017.12.002","article-title":"Evaluation of the hypothesis that phasic dopamine constitutes a cached-value signal","volume":"153","author":"Sharpe","year":"2018","journal-title":"Neurobiol. Learn. Mem."},{"key":"10.1016\/j.neuropharm.2020.108374_bib111","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1523\/JNEUROSCI.16-24-08057.1996","article-title":"Effects of chronic treatment with \u03949-tetrahydrocannabinol on cannabinoid-stimulated [35S] GTP\u03b3S autoradiography in rat brain","volume":"16","author":"Sim","year":"1996","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib112","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.drugalcdep.2019.02.020","article-title":"Self-administration of edible \u03949-tetrahydrocannabinol and associated behavioral effects in mice","volume":"199","author":"Smoker","year":"2019","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2020.108374_bib113","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1111\/j.1471-4159.2006.03880.x","article-title":"Anandamide administration alone and after inhibition of fatty acid amide hydrolase (FAAH) increases dopamine levels in the nucleus accumbens shell in rats","volume":"98","author":"Solinas","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2020.108374_bib114","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2174\/1389557516666161004162133","article-title":"Cannabis: a treasure trove or pandora's box?","volume":"17","author":"Solymosi","year":"2017","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.neuropharm.2020.108374_bib115","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00213-012-2839-1","article-title":"Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats","volume":"225","author":"Spano","year":"2013","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib116","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1016\/j.biopsych.2018.04.016","article-title":"A model of \u03949-tetrahydrocannabinol self-administration and reinstatement that alters synaptic plasticity in nucleus accumbens","volume":"84","author":"Spencer","year":"2018","journal-title":"Biol. Psychiatr."},{"key":"10.1016\/j.neuropharm.2020.108374_bib117","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1002\/cne.23880","article-title":"Components and characteristics of the dopamine reward utility signal","volume":"524","author":"Stauffer","year":"2016","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.neuropharm.2020.108374_bib118","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.neuroimage.2009.06.029","article-title":"Can recreational doses of THC produce significant dopamine release in the human striatum?","volume":"48","author":"Stokes","year":"2009","journal-title":"Neuroimage"},{"key":"10.1016\/j.neuropharm.2020.108374_bib119","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1046\/j.1460-9568.2002.02041.x","article-title":"SHORT COMMUNICATION Inhibition of GABAergic neurotransmission in the ventral tegmental area by cannabinoids","volume":"15","author":"Szabo","year":"2002","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib120","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1126\/science.276.5321.2048","article-title":"Cannabinoid and heroin activation of mesolimbic dopamine transmission by a common \u03bc1 opioid receptor mechanism","volume":"276","author":"Tanda","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuropharm.2020.108374_bib121","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0376-8716(02)00223-5","article-title":"The structure of cannabis dependence in the community","volume":"68","author":"Teesson","year":"2002","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2020.108374_bib122","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/0014-2999(94)90003-5","article-title":"Evidence for a bidirectional cross-tolerance between morphine and \u03949-tetrahydrocannabinol in mice","volume":"260","author":"Thorat","year":"1994","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108374_bib123","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1056\/NEJMp1505328","article-title":"Synthetic cannabinoid-related illnesses and deaths","volume":"373","author":"Trecki","year":"2015","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuropharm.2020.108374_bib124","doi-asserted-by":"crossref","first-page":"5426","DOI":"10.1523\/JNEUROSCI.0079-11.2011","article-title":"Cannabinoid receptor blockade reduces the opportunity cost at which rats maintain operant performance for rewarding brain stimulation","volume":"31","author":"Trujillo-Pisanty","year":"2011","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib125","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1046\/j.0953-816x.2001.01558.x","article-title":"\u03949\u2010tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect","volume":"13","author":"Valverde","year":"2001","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib126","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.brainres.2010.06.032","article-title":"GABAA receptor density is altered by cannabinoid treatment in the hippocampus of adult but not adolescent rats","volume":"1351","author":"Verdurand","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2020.108374_bib127","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1038\/sj.npp.1300117","article-title":"Chronic morphine modulates the contents of the endocannabinoid, 2-arachidonoyl glycerol, in rat brain","volume":"28","author":"Vigan\u00f2","year":"2003","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib128","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pbb.2005.01.021","article-title":"Molecular and cellular basis of cannabinoid and opioid interactions","volume":"81","author":"Vigano","year":"2005","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuropharm.2020.108374_bib129","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/j.cell.2015.07.046","article-title":"The brain on drugs: from reward to addiction","volume":"162","author":"Volkow","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.neuropharm.2020.108374_bib130","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1038\/nrn.2017.130","article-title":"The dopamine motive system: implications for drug and food addiction","volume":"18","author":"Volkow","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2020.108374_bib131","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0925-4927(01)00104-4","article-title":"Cannabis induced dopamine release: an in-vivo SPECT study","volume":"107","author":"Voruganti","year":"2001","journal-title":"Psychiatr. Res. Neuroimaging"},{"key":"10.1016\/j.neuropharm.2020.108374_bib132","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/j.celrep.2015.08.041","article-title":"Cocaine-induced endocannabinoid mobilization in the ventral tegmental area","volume":"12","author":"Wang","year":"2015","journal-title":"Cell Rep."},{"key":"10.1016\/j.neuropharm.2020.108374_bib133","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0376-8716(03)00135-2","article-title":"Functional consequences of the repeated administration of \u03949-tetrahydrocannabinol in the rat","volume":"71","author":"Whitlow","year":"2003","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.neuropharm.2020.108374_bib134","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0014-2999(03)01856-9","article-title":"Cannabinoid pharmacological properties common to other centrally acting drugs","volume":"471","author":"Wiley","year":"2003","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2020.108374_bib135","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.jpeds.2012.12.056","article-title":"Exposure to bath salts and synthetic tetrahydrocannabinol from 2009 to 2012 in the United States","volume":"163","author":"Wood","year":"2013","journal-title":"J. Pediatr."},{"key":"10.1016\/j.neuropharm.2020.108374_bib136","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0028-3908(99)00140-9","article-title":"Effects of chronic \u03949-tetrahydrocannabinol on rat midbrain dopamine neurons: an electrophysiological assessment","volume":"39","author":"Wu","year":"2000","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2020.108374_bib137","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1038\/sj.npp.1301552","article-title":"Cannabinoid CB1 receptor antagonists attenuate cocaine's rewarding effects: experiments with self-administration and brain-stimulation reward in rats","volume":"33","author":"Xi","year":"2008","journal-title":"Neuropsychopharmacology"}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820304421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390820304421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T07:08:41Z","timestamp":1758438521000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390820304421"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":138,"alternative-id":["S0028390820304421"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108374","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chronic cannabinoid exposure produces tolerance to the dopamine releasing effects of WIN 55,212\u20132 and heroin in adult male rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2020.108374","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108374"}}